Project Grant R43DK143795
Award Date
7/1/25
Completion Date
6/30/26
Dollars Obligated
$298K
Similar Awards
This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), which falls under CFDA program 93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research, provides $704,672 to Flowpoint Medical Inc. to develop an implantable device that aims to improve vascular access and the safety of hemodialysis treatments for patients with end-stage kidney disease. The funding will be used to refine the manufacturability and operational parameters of the...
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $499,890 Project Grant (CFDA 93.847 - Diabetes, Digestive, and Kidney Diseases Extramural Research) to Pavaj Vascular Corporation in Rochester, MN. The purpose of this 2-year grant is to develop and evaluate a novel therapy using nanoparticles encapsulated with vitamin D3 to reduce venous stenosis and neointimal hyperplasia in arteriovenous fistulas, which are critical for effective hemodialysis in patients...
This Project Grant award from the National Science Foundation (NSF) Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084) provides $274,811 to Anova Biomedical, Inc. to develop 3D printed personalized vascular grafts using novel elastomeric resins. The key objectives are to: 1) develop and characterize the novel 3D printing resin for producing personalized, elastic, and bioresorbable vascular grafts; 2) demonstrate the ability to 3D print vascular prosthetics using patient CT...
This federal Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), aims to develop a catheter end cap with an antimicrobial luminal insert to reduce the risk of bloodstream infections in hemodialysis patients. The $591,844 grant to Allvivo Vascular, Inc. will support the development and testing of the "Gatekeeper Antimicrobial Barrier Cap"...
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $809,595 Project Grant under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to Boston Medical Center Corporation. The grant supports research to evaluate the use of intravascular ultrasound (IVUS) in diagnosing and managing arteriovenous (AV) access dysfunction in end-stage kidney disease patients on hemodialysis. Key objectives include assessing the superiority of...
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a 5-year, $518,661 Project Grant under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to Vanderbilt University Medical Center (VUMC). The grant, titled "Beyond Urea Kinetics: Balancing Tradeoffs in Dialyzer Design for the Next 50 Years," aims to improve dialysis treatment for the 548,000 Americans who rely on it for kidney failure. The research will focus on...
This federal Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), provides $200,000 in funding to the University of North Carolina at Chapel Hill (UNC-CH) from September 17, 2024 to September 16, 2025. The funding supports research aimed at investigating the effect of NRF-2 activation in vascular smooth muscle cells (VSMCs) and in a mouse arteriovenous...
The federal Project Grant award R43DK137616 for $275,766.00 was provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The award funds Biosurfaces Inc., a for-profit medical device company, to develop and evaluate an implantable, electrospun cell chamber device loaded with human pancreatic islets. The device aims to provide an immune-protected environment to support...
This $543,826 Project Grant was awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The grant supports research at the University of Pittsburgh to develop novel bioengineered regenerative medicine solutions for promoting vascular tissue regeneration and wound healing. The key objectives are to: 1) Test the significance of vasculogenic fibroblasts in tissue repair...
This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), provides $3,740,270 to Biomedinnovations, Inc. (BMI) to develop a subnormothermic oxygenated perfusion platform for extended preservation of high-risk kidney grafts. The goal is to improve the viability and acceptance of kidneys from older donors and donors after circulatory death, which often...